NCT06717906

Brief Summary

This study aims to evaluate the correlation of rectal wall thickness and vascularity measurements using trans-abdominal ultrasound (TAS), trans-perineal ultrasound (TPUS), and endoscopic ultrasound (EUS) in adult patients with ulcerative colitis (UC). The primary objective is to correlate rectal total wall thickness measured by TPUS with EUS, while secondary objectives include correlating rectal wall thickness and vascularity as measured by TAS, TPUS, and EUS, with endoscopic and histologic activity. Additionally, the study will assess changes in patient management following EUS/sigmoidoscopy compared to TAS/TPUS alone. Consecutive UC patients attending an IBD clinic will undergo clinical assessment using the Simple Clinical Colitis Activity Index (SCCAI) followed by TAS and TPUS as point-of-care tests. If clinically indicated, patients will also undergo sigmoidoscopy and EUS during the same visit, with measurements compared and correlated to histologic inflammation and fecal calprotectin (FCP) levels when available. This cross-sectional study will include a follow-up period until biopsy results are obtained, with a recruitment duration of 6-12 months and a target sample size of 170 patients (60 patients with mid-end ultrasound machine, rest with high-end ultrasound machine for transabdominal and transperineal ultrasound).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 27, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 18, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 5, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

July 17, 2025

Status Verified

December 1, 2024

Enrollment Period

10 months

First QC Date

August 18, 2024

Last Update Submit

July 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compare diagnostic accuracy of endoscopic ultrasound in predicting endoscopic remission

    Wall thickness (in mm) measured by endoscopic ultrasound in predicting endoscopic remission in rectum in ulcerative colitis

    Baseline

Secondary Outcomes (7)

  • Compare diagnostic accuracy of endoscopic ultrasound in predicting histologic remission

    Baseline

  • Compare diagnostic accuracy of endoscopic ultrasound vascularity in predicting histologic remission

    Baseline

  • Compare diagnostic accuracy of transperineal ultrasound vascularity in predicting histologic remission

    Baseline

  • Compare diagnostic accuracy of transperineal ultrasound in predicting endoscopic remission

    Baseline

  • Compare diagnostic accuracy of transperineal ultrasound in predicting histlogic remission

    Baseline

  • +2 more secondary outcomes

Study Arms (1)

Adult patients with Ulcerative colitis

OTHER

Adult patients (18-75 years) with Ulcerative colitis Pregnant, lactating and acute severe colitis excluded

Diagnostic Test: Endoscopic Ultrasound

Interventions

Endoscopic UltrasoundDIAGNOSTIC_TEST

If sigmoidoscopy is warranted as per clinical indication, the consenting patients shall undergo endoscopic ultrasound (EUS) using a radial echo-endoscope during the same sitting of sigmoidoscopy without incurring any additional cost to the patient. Total rectal wall thickness in anterior and posterior wall shall be measured in upper, middle and lower rectum with assessment of vascularity (Modified Limberg scale). The maximal wall thickness including maximum mucosal and submucosal thickness shall be noted and compared to total wall thickness measured by transabdominal ultrasound (TAS) and Transperineal ultrasound (TPUS). On sigmoidoscopy, rectal inflammation shall be measured by ulcerative colitis endoscopic index of severity (UCEIS) in rectum. Biopsy seal be taken as standard protocol to document histologic inflammation (measured by Nancy histologic index) which is known to predict future risk of relapse.

Adult patients with Ulcerative colitis

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (18-75 years) with Ulcerative colitis

You may not qualify if:

  • Pregnant
  • Lactating mother
  • Endoscopy not required
  • No consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asian Institute of Gastroenterology

Hyderabad, India

Location

MeSH Terms

Conditions

Colitis, Ulcerative

Interventions

Endosonography

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesInflammatory Bowel DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

UltrasonographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2024

First Posted

December 5, 2024

Study Start

May 27, 2024

Primary Completion

March 31, 2025

Study Completion

March 31, 2025

Last Updated

July 17, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations